The story has been updated to include comments from Qiagen's conference call this morning.

NEW YORK (GenomeWeb News) – Qiagen said after the close of the market on Tuesday that its fourth-quarter revenues increased 4 percent year over year at constant exchange rates.

For the three months ended Dec. 31, 2012, the firm posted $346.5 million in revenues, up from $334.4 a year ago and surpassing the consensus Wall Street estimate of $327.8 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.